News & Media

A Letter to Our Customers

  • by
  • Sep 28, 2021
Newport barn

Dear Valued Customer,

Boehringer Ingelheim has reached an agreement to sell Newport Laboratories, which manufactures custom-made vaccines for swine and cattle, to Vaxxinova.

By prioritizing our investments and focusing on key brands in our livestock portfolios, we believe we can deliver the greatest value to customers and ensure long-term growth and success in a dynamic and evolving business environment. 

Newport Laboratories, Inc. announces recipient of inaugural Lex Thompson Veterinary Investigator Award

  • by
  • May 26, 2021
Luke Daniels

New award helps veterinary students pursue research into cattle health

WORTHINGTON, Minn. (May 26, 2021) – Newport Laboratories, Inc., a Boehringer Ingelheim company, is proud to announce the recipient of the first-ever Lex Thompson Veterinary Investigator Award. The award, which will be given annually to a veterinary student, recognizes an outstanding research proposal and provides the tools and support necessary to complete it.

Pinkeye: New Challenges Call for New Solutions

  • by
  • Mar 26, 2021

Cattle herds exposed to infectious bovine keratoconjunctivitis, more commonly known as pinkeye, are at risk of lower calf-growth rate, potential blindness and permanent damage if left untreated.1 It’s estimated that pinkeye causes annual losses of more than $150 million in the United States, affecting over 10 million calves.

With an emerging species of pinkeye bacteria overtaking the previously predominant species, controlling this increasingly complex disease is challenging for many producers and veterinarians. But there are tools that can help.

One-Dose Adjuvant Saves Time, Cost by Removing Need for Booster Shots

  • by
  • Mar 22, 2021

Newport Laboratories, Inc., a leader in custom-made vaccines, is proud to offer Bio One™, a proprietary one-dose adjuvant that helps reduce time, labor and expense by removing the need for booster shots.

Many bovine custom-made vaccines require an initial administration and a second booster shot several weeks later, but due to the added labor cost and logistical challenges associated with administering the second dose, it is commonly overlooked. This can compromise the effectiveness of the vaccine.

Adjuvants: The Biggest Variable in a Vaccine

  • by
  • Jul 19, 2019

There are two basic ingredients in killed vaccines: antigens and adjuvants. While antigens are well understood, there’s far less understanding of the critical role adjuvants play in vaccines’ ability to do their job. But not all adjuvants are the same, and identifying which adjuvant has the right properties to help solve a herd’s health challenges can give producers and veterinarians peace of mind that they’re giving the best possible vaccine to their animals.

3 Key Advancements in the Fight Against Strep

  • by
  • Apr 19, 2019

As producers continue to reduce the amount of antibiotics given to their herds, many are looking to other options to fight Streptococcus suis, more commonly known as Strep suis

The pathogen is one of the primary causes of bacterial meningitis in pigs,1 and can cause illness at any stage of production, with associated mortality rates of up to 20 percent.2 With infections often existing subclinically and nearly 100 percent of pigs serving as carriers of the bacteria,3Strep suis is a key concern for many producers. 

Newport Laboratories is now part of Boehringer Ingelheim

  • by
  • Jun 12, 2018

DULUTH, Ga. — [June 12, 2018]

Boehringer Ingelheim (BI) is excited to announce that Newport Laboratories, Inc. in Worthington, Minnesota, is officially part of Boehringer Ingelheim’s animal health business unit.

Newport Laboratories enhances the service and product offerings for BI customers. By providing cutting-edge diagnostics like whole genome sequencing, metagenomics, and bioinformatics, Newport Laboratories crafts custom, autogenous vaccines that target the specific viruses or bacteria causing disease in individual livestock operations.

Scrambled eggs with a side of molecular biology

  • by
  • May 05, 2017
Dr. Priya Anbalagan

 (May 5, 2017) – Dr. Priya Anbalagan added molecular biology to the menu during the Academy of Veterinary Consultants 2017 Spring Conference in Irving, Texas, March 30 through April 1. Anbalagan, senior scientist and manager of Diagnostic Services and Technology Development, Newport Laboratories, Inc., presented her research on state-of-the-art diagnostics and bovine respiratory disease to more than 130 veterinarians at a breakfast sponsored by Merial.

Anbalagan demonstrated how Newport is using cutting edge molecular technology to evaluate genetic variations of pathogens.

Randy Shirbroun talks pathology and prevention of diseases

  • by
  • Jun 24, 2016

WORTHINGTON, Minn. – Veterinarian Randy Shirbroun of Newport Laboratories Inc. addressed more than 200 bison producers regarding the pathology and prevention of diseases caused by Mycoplasma bovis. The producers had gathered for the 2016 National Bison Association Summer Conference held in June at Elk River, Minnesota. Shirbroun specializes in ruminant health issues including those seen in the American bison, which became the official U.S. national mammal in May.